Skip to main content

Fathom Therapeutics

New York, United States

Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.

$31.1M raised
Apr 2026
Series A

Top Investors

ChemistrySutter Hill VenturesAlexandria Venture InvestmentsNew York VenturesBikui Chen

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Fathom Therapeutics

How much funding has Fathom Therapeutics raised?
Fathom Therapeutics has raised $31.1M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Who are Fathom Therapeutics's investors?
Fathom Therapeutics's investors include Chemistry, Sutter Hill Ventures, Alexandria Venture Investments, New York Ventures, Bikui Chen.
Where is Fathom Therapeutics headquartered?
Fathom Therapeutics is headquartered in New York, United States.
What does Fathom Therapeutics do?
Fathom Therapeutics focuses on drug design by harnessing biomolecular motion to develop therapeutics that can reprogram protein function.
What stage is Fathom Therapeutics at?
Fathom Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Fathom Therapeutics — Funding & Investors." VCBacked, April 27, 2026, https://www.vcbacked.co/company/fathom-therapeutics. Accessed June 16, 2026.
APA
VCBacked. (2026). Fathom Therapeutics — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/fathom-therapeutics
Wikipedia (cite web)
{{cite web |title=Fathom Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/fathom-therapeutics |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .